176 related articles for article (PubMed ID: 32197606)
1. Role of limonin in anticancer effects of Evodia rutaecarpa on ovarian cancer cells.
Bae JR; Park WH; Suh DH; No JH; Kim YB; Kim K
BMC Complement Med Ther; 2020 Mar; 20(1):94. PubMed ID: 32197606
[TBL] [Abstract][Full Text] [Related]
2. Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells.
Chen TC; Chien CC; Wu MS; Chen YC
Phytomedicine; 2016 Jan; 23(1):68-78. PubMed ID: 26902409
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract.
Iwata H; Tezuka Y; Kadota S; Hiratsuka A; Watabe T
Drug Metab Pharmacokinet; 2005 Feb; 20(1):34-45. PubMed ID: 15770073
[TBL] [Abstract][Full Text] [Related]
4. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
Yang J; Li G; Zhang K
Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
[TBL] [Abstract][Full Text] [Related]
5. Ethanol Extract of
Park E; Lee MY; Seo CS; Jang JH; Kim YU; Shin HK
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690562
[TBL] [Abstract][Full Text] [Related]
6. Mechanism and Pharmacodynamic Substance Basis of Raw and Wine-Processed
Liu Y; Li H; Chen L; Zhao H; Liu J; Gong S; Ma D; Chen C; Zeng S; Long H; Ren W
Pain Res Manag; 2023; 2023():7711988. PubMed ID: 37305097
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by ethanol extract of Evodia rutaecarpa in HeLa human cervical cancer cells via activation of AMP-activated protein kinase.
Park SY; Park C; Park SH; Hong SH; Kim GY; Hong SH; Choi YH
Biosci Trends; 2017 Jan; 10(6):467-476. PubMed ID: 27890875
[TBL] [Abstract][Full Text] [Related]
8. PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway.
Yang X; Zhang Q; Yang X; Zhao M; Yang T; Yao A; Tian X
Biochem Biophys Res Commun; 2019 Apr; 511(4):719-724. PubMed ID: 30827507
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
10. [Optimization of a HPLC determination method for Evodia rutaecarpa].
Huang Z; Yi J; Wu Y; Liu Y; Chen Y; Liu Y
Zhongguo Zhong Yao Za Zhi; 2011 Feb; 36(4):478-80. PubMed ID: 21598546
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer effect of Scutellaria baicalensis in combination with cisplatin in human ovarian cancer cell.
Choi BY; Joo JC; Lee YK; Jang IS; Park SJ; Park YJ
BMC Complement Altern Med; 2017 May; 17(1):277. PubMed ID: 28545442
[TBL] [Abstract][Full Text] [Related]
12. A new limonoid from the fruits of Evodia rutaecarpa (Juss.) Benth.
Teng J; Yang XW
Pharmazie; 2006 Dec; 61(12):1038-40. PubMed ID: 17283664
[TBL] [Abstract][Full Text] [Related]
13. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.
Mir R; Tortosa A; Martinez-Soler F; Vidal A; Condom E; Pérez-Perarnau A; Ruiz-Larroya T; Gil J; Giménez-Bonafé P
Int J Cancer; 2013 Apr; 132(7):1525-36. PubMed ID: 22961628
[TBL] [Abstract][Full Text] [Related]
14. Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.
Tu Y; Kim E; Gao Y; Rankin GO; Li B; Chen YC
Int J Oncol; 2016 Jun; 48(6):2657-65. PubMed ID: 27082635
[TBL] [Abstract][Full Text] [Related]
15. New limonoids and quinolone alkaloids with cytotoxic and anti-platelet aggregation activities from Evodia rutaecarpa (Juss.) Benth.
Qin J; Liao CN; Chen WW; Li HY; Su J; Wu XD; He JB; Zhang GH
Fitoterapia; 2021 Jul; 152():104875. PubMed ID: 33675886
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer.
Pashaei-Asl F; Pashaei-Asl R; Khodadadi K; Akbarzadeh A; Ebrahimie E; Pashaiasl M
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1483-1487. PubMed ID: 28884602
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
Coukos G; Makrigiannakis A; Kang EH; Rubin SC; Albelda SM; Molnar-Kimber KL
Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
[TBL] [Abstract][Full Text] [Related]
18. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
Zhang X; Qi Z; Yin H; Yang G
Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
20. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
